Lactoferrin 1 11

Drug Profile

Lactoferrin 1 11

Alternative Names: hLF 1-11

Latest Information Update: 26 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AM-Pharma Holding
  • Developer AM-Pharma
  • Class Antibacterials; Peptides
  • Mechanism of Action Chelating agents; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Suspended Bacteraemia; Bacterial infections; Candidaemia; Mycoses

Most Recent Events

  • 01 Oct 2007 Data presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC-2007) added to the Bacterial Infections and Mycoses antimicrobial activity and pharmacodynamics sections
  • 30 Oct 2006 Data presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2006) have been added to the Mycoses pharmacodynamics section
  • 10 Aug 2006 Phase-II clinical trials in Mycoses in Netherlands (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top